CIK 0001200375 · Non-accelerated filer<br>Smaller reporting company
CODEXIS, INC.
Sign in to watch- Ticker
- CDXS
- Exchange
- Nasdaq
- Industry
- Industrial Organic Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 710872999
- Phone
- 650-421-8100
- Business address
- 200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063
- Former names
- CODEXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,446
- in 3 filings
Net −$18,446. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-08 | KELLEY BERNARD J Director | Sale | −20,000 | $18.72 | $374K | 208,636 |
| 2021-03-08 | KELLEY BERNARD J Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2021-03-05 | TAYLOR DEAN ROSS JR SVP, Chief Financial Officer | Shares withheld for taxes | −2,419 | $19.51 | $47K | 23,565 |
| 2021-02-16 | NICOLS JOHN J President and CEO | Grant or award · Stock Option (Right to Buy) | +198,000 | 198,000 | ||
| 2021-02-16 | NICOLS JOHN J President and CEO | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2021-02-16 | TAYLOR DEAN ROSS JR SVP, Chief Scientific Officer | Grant or award | +14,080 | 20,984 | ||
| 2021-02-16 | TAYLOR DEAN ROSS JR SVP, Chief Scientific Officer | Grant or award | +5,000 | 25,984 | ||
| 2021-02-16 | TAYLOR DEAN ROSS JR SVP, Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-02-16 | TAYLOR DEAN ROSS JR SVP, Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +17,600 | 17,600 | ||
| 2021-02-11 | TAYLOR DEAN ROSS JR SVP, Chief Scientific Officer | Shares withheld for taxes | −1,096 | $26.67 | $29K | 6,904 |
| 2021-02-02 | Martinborough Esther Director | Grant or award | +7,262 | 7,262 | ||
| 2021-01-21 | KELLEY BERNARD J Director | Sale | −2,500 | $24.98 | $62K | 208,636 |
| 2021-01-21 | Dorgan Byron L Director | Option exercise | +25,000 | $10.63 | $266K | 187,790 |
| 2021-01-21 | Dorgan Byron L Director | Sale | −25,000 | $25.17 | $629K | 162,790 |
| 2021-01-21 | Dorgan Byron L Director | Option exercise · Stock Option (Right to Buy) | −25,000 | 0 | ||
| 2021-01-20 | Dorgan Byron L Director | Option exercise | +25,000 | $10.63 | $266K | 187,790 |
| 2021-01-20 | Dorgan Byron L Director | Sale | −25,000 | $26.75 | $669K | 162,790 |
| 2021-01-20 | Dorgan Byron L Director | Option exercise · Stock Option (Right to Buy) | −25,000 | 25,000 | ||
| 2020-12-21 | WOLF DENNIS P Director | Sale | −10,000 | $19.99 | $200K | 51,129 |
| 2020-10-21 | KELLEY BERNARD J Director | Sale | −2,500 | $14.00 | $35K | 211,136 |
Page 16 of 38 · 744 trades